| HBPV | Haemophilus influenza type B Polysaccharide(PRP) Vaccine; B형 헤모필루스 인플루엔자 피막 다당질 백신... |
|---|---|
| HIB | heart infusion broth; hemolytic immune body; Hemophilus influenzae type B [vaccine] |
| HITB, HiTB | Hemophilus influenzae type B |
| ALL | Acute Lymphocytic Leukemia 형태학적 분류 L1; Small, Homogenous(... |
| MEN | Multiple Endocrine Neoplasia ; AD Trait 1. MEN Type I(= Wermer Syndro... |
| Haemophilus influenza | <bacteria> A gram-negative bacteria that is a common cause for epiglottitis, meningitis, conjunctivitis, sepsis and respiratory infections. Haemophilus influenza type b is a gram-negative bacteria that is responsible for a significant percentage of bacterial sepsis (blood-borne infection) cases in infants under 4 months of age (pneumonia, epiglottitis, sepsis, septic arthritis, cellulitis). There is a new vaccination available to protect against this common infant pathogen (HIB vaccine, haemophilus influenza b vaccine). (27 Sep 1997) |
|---|---|
| Haemophilus influenza b vaccine | <virology> A vaccination that is given to infants to protect against infection with haemophilus influenza b, an important cause of neonatal sepsis. Typically administered at 2, 4, 6 and 15 months. Children who are aged 15 months to 5 years, who have not received the vaccine, should be given a single injection of haemophilus b conjugate vaccine. Acronym: HIB (26 Mar 1998) |
| Haemophilus influenza meningitis | <disease> A form of meningitis caused by the bacterium haemophilus influenza. Inflammation of the membranes (meninges) covering the brain and spinal cord can result after infection with this organism. Influenza meningitis occurs most frequently in children under 5 years old. Onset may be sudden or occur more slowly after an upper respiratory infection. Symptoms and features include fever, headache, stiff neck, photophobia and mental status changes. Infants may be irritable and exhibit poor feeding associated with fever. Severe cases may progress to seizures, coma and death. Treatment always includes high-dose systemic antibiotics and corticosteroids may also be used in some select cases. (27 Sep 1997) |
| Haemophilus paragallinarum | <bacteria> A species that causes infectious coryza in chickens and other birds. (05 Mar 2000) |
| Haemophilus parahaemolyticus | <bacteria> A species found in the upper respiratory tract and associated frequently with pharyngitis; occasionally causes subacute endocarditis. (05 Mar 2000) |
| Haemophilus parainfluenzae | <bacteria> A species which is usually nonpathogenic but which occasionally causes subacute endocarditis. (05 Mar 2000) |
| Haemophilus parasuis | <bacteria> A species causing Glasser's disease in pigs. (05 Mar 2000) |
| Haemophilus somnus | <bacteria> A species causing thromboembolic meningoencephalitis in cattle. (05 Mar 2000) |
| Haemophilus suis | <bacteria> A species, related to Haemophilus influenzae, found in swine and associated with influenza virus in the pneumonia of swine influenza. (05 Mar 2000) |
| haemophilus vaccines | Vaccines or candidate vaccines containing antigenic polysaccharides from haemophilus influenzae and designed to prevent infection. The vaccine can contain the polysaccharides alone or more frequently polysaccharides conjugated to carrier molecules. It is also seen as a combined vaccine with diphtheria-tetanus-pertussis vaccine. (12 Dec 1998) |
| factor X for Haemophilus | <physiology> A substance, in the form of reddish brown, microscopic, prismatic crystals, formed from dried blood by the action of strong acetic acid and common salt; called also Teichmann's crystals. Chemically, it is a hydrochloride of haematin. The obtaining of these small crystals, from old blood clots or suspected blood stains, constitutes one of the best evidences of the presence of blood. Origin: Gr. Blood. Source: Websters Dictionary (01 Mar 1998) |
| active immunization | The production of active immunity. (05 Mar 2000) |
| anthrax immunization | A series of six shots over six months and booster shots annually, the anthrax vaccine now in use in the USA was first developed in the 1950s and approved by the Food and Drug Administration for general use in 1970. It is produced by the Michigan Biologic Products Institute of Michigan's Department of Health and is given routinely to veterinarians and others working with livestock. In December, 1997 it was announced that all US military would receive the vaccine, as do the military in the UK and Russia, the reason being concern that anthrax might be used in biologic warfare. (12 Dec 1998) |
| german measles immunization | The standard MMR vaccine is given to prevent measles, mumps and rubella (German measles). The MMR vaccine is now given in two dosages. The first should be given at12-15 months of age. The second vaccination should be given at 4-6 years (or, alternatively, 11-12 years) of age. most colleges require proof of a second measles or MMR vaccination prior to entrance. Most children should receive MMR vaccinations. Exceptions may include children born with an inability to fight off infection, some children with cancer, on treatment with radiation or drugs for cancer, on long term steroids (cortisone). People with severe allergic reactions to eggs or the drug neomycin should probably avoid the MMR vaccine. Pregnant women should wait until after delivery before being immunised with MMR. People with HIV or AIDS should normally receive MMR vaccine. Measles, mumps, and rubella vaccines may be administered as individual shots, if necessary, or as a measles-rubella combination. (12 Dec 1998) |
| passive immunization | The production of passive immunity. (05 Mar 2000) |